Form 4: BDX Executive David Shan Reports Equity Awards, Vesting

Becton Dickinson's EVP and Chief ISC Officer, David Shan, reported the acquisition of 4,529 shares through equity awards and vesting, alongside a disposition of 134 shares for tax withholding, pursuant to a Rule 10b5-1 plan.

Summary

• David Shan, EVP and Chief ISC Officer of Becton, Dickinson and Company (BDX), reported changes in his beneficial ownership of common stock, made pursuant to a Rule 10b5-1 plan.
• On November 26, 2025, Shan is scheduled to acquire 3,504 shares of common stock as restricted stock units (RSUs) awarded under the company's 2004 Employee and Director Equity-Based Compensation Plan.
• On the same date, he is scheduled to acquire an additional 1,025 shares upon the vesting of performance-based equity awards.
• Also on November 26, 2025, 134 shares are scheduled to be disposed of to cover withholding taxes related to the vesting of performance units and previously reported RSUs.
• Following these transactions, David Shan will directly beneficially own 8,970 shares of Becton, Dickinson and Company common stock.

Sentiment

Score: 7

Explanation: The filing reports routine executive equity compensation events, including RSU awards and performance share vesting, which are standard practices and pre-planned under a Rule 10b5-1 plan. The increase in beneficial ownership aligns executive interests with shareholders, while the tax-related disposition is a normal occurrence, leading to a neutral to slightly positive sentiment.

Positives

• Scheduled acquisition of 3,504 shares through restricted stock unit awards, indicating ongoing equity compensation for the executive.
• Scheduled acquisition of 1,025 shares from the vesting of performance-based equity awards, suggesting the achievement of performance targets.
• The transactions will increase direct beneficial ownership to 8,970 shares, further aligning executive interests with shareholders.

Negatives

• Scheduled disposition of 134 shares for tax withholding, which is a standard practice but reduces the total number of shares held by the executive.

Future Outlook

NA

Industry Context

This filing reflects routine executive compensation practices within the medical technology and healthcare industry, where equity awards like RSUs and performance-based shares are common tools to incentivize and retain key management personnel. Such awards align executive interests with long-term company performance and shareholder value.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) and performance-based equity awards for executive compensation is a standard practice across the medical technology and broader S&P 500 companies, comparable to compensation structures at peers like Medtronic (MDT) or Abbott Laboratories (ABT).
• The disposition of shares for tax withholding upon vesting is also a common and expected procedure for equity compensation, consistent with practices observed in similar executive compensation plans across various industries.

Stakeholder Impact

• Shareholders: The increase in executive beneficial ownership aligns management's interests with shareholder value creation.
• Employees: Reflects the company's ongoing use of equity compensation to incentivize key personnel.

Key Dates

Recommendation

This Form 4 filing details routine executive equity compensation, including RSU awards, performance share vesting, and tax-related dispositions, all executed under a Rule 10b5-1 plan. These are standard, pre-planned events and do not indicate any new fundamental information about Becton Dickinson's operational performance or strategic direction that would warrant a change in investment recommendation. The transactions are expected and do not suggest a significant positive or negative catalyst for the stock price.

Keywords

Becton Dickinson, BDX, Form 4, Insider Trading, Equity Awards, Restricted Stock Units, Performance Shares, Executive Compensation, David Shan, Beneficial Ownership, Rule 10b5-1